Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group..

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

PMID:
27995656
2.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group..

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

PMID:
26549003
3.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group..

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
4.

Odour quality of spray-dried hens' egg powders: the influence of composition, processing and storage conditions.

Rannou C, Texier F, Moreau M, Courcoux P, Meynier A, Prost C.

Food Chem. 2013 Jun 1;138(2-3):905-14. doi: 10.1016/j.foodchem.2012.11.090. Epub 2012 Nov 28.

PMID:
23411195
5.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group..

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23.

PMID:
22271569
6.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group..

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.

PMID:
21708105
7.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group..

Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.

PMID:
19837455
8.

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.

Walter M, Philotheou A, Bonnici F, Ziegler AG, Jimenez R; NBI-6024 Study Group..

Diabetes Care. 2009 Nov;32(11):2036-40. doi: 10.2337/dc09-0449. Epub 2009 Aug 18.

9.

Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.

Louvet A, Diaz E, Dharancy S, Coevoet H, Texier F, Thévenot T, Deltenre P, Canva V, Plane C, Mathurin P.

J Hepatol. 2008 Mar;48(3):465-70. doi: 10.1016/j.jhep.2007.10.010. Epub 2007 Nov 26.

PMID:
18164508
10.

The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P.

Hepatology. 2007 Jun;45(6):1348-54.

PMID:
17518367
11.

[Acute recurrent pancreatitis in a composite CFTR heterozygote and Spink1 heterozygote patient].

Texier F, Lalau G, Dumur V, Louvet A, Dharancy S, Maunoury V, Bulois P, Ernst O, Mathurin P.

Gastroenterol Clin Biol. 2006 Apr;30(4):630-1. French. No abstract available.

12.

Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis.

Louvet A, Texier F, Dharancy S, Pruvot FR, Sergent G, Deltenre P, Ernst O, Paris JC, Mathurin P.

Dig Dis Sci. 2006 Jan;51(1):11-7. No abstract available.

PMID:
16416202
13.

[Acute necrotic alcoholic pancreatitis with Cullen and Grey Turner signs].

Texier F, Couignoux S, Duval A, Bulois P, Delaporte E, Paris JC.

Gastroenterol Clin Biol. 2004 Aug-Sep;28(8-9):811-2. French. No abstract available.

PMID:
15646544
14.

Evaluation of amantadine in chronic hepatitis C: a meta-analysis.

Deltenre P, Henrion J, Canva V, Dharancy S, Texier F, Louvet A, De Maeght S, Paris JC, Mathurin P.

J Hepatol. 2004 Sep;41(3):462-73.

PMID:
15336450
15.

[Membranous glomerulonephritis complicating hepatocellular carcinoma].

Texier F, Dharancy S, Provot F, Augusto D, Mortier PE, Mathurin P, Copin MC, Paris JC.

Gastroenterol Clin Biol. 2004 Jun-Jul;28(6-7 Pt 1):605-7. French.

16.

[Alcoholic hepatitis: pathophysiological data and therapeutic perspectives].

Mathurin P, Dharancy S, Malapel M, Deltenre P, Texier F, Paris JC.

Gastroenterol Clin Biol. 2004 May;28(5 Suppl):D103-11. Review. French. No abstract available.

17.

[Atypical focal nodular hyperplasia].

Béchade D, Algayres JP, Ehre P, Texier F, Foehrenbach H, Bili H, Hélie C, Coutant G, Daly JP.

Rev Med Interne. 2001 Mar;22(3):310-3. French. No abstract available.

PMID:
11270279
18.

[Malignant humoral hypercalcemia complicating hepatocellular carcinoma and rectal adenocarcinoma].

Béchade D, Algayres JP, Texier F, Bili H, Mennecier D, Hélie C.

Presse Med. 2000 Dec 9;29(38):2096. French. No abstract available.

PMID:
11147049
19.

Relative phase measurement of a stark wave packet in the vicinity of the saddle point

Rella CW, Texier F, Noordam LD, Robicheaux F.

Phys Rev Lett. 2000 Nov 13;85(20):4233-6.

PMID:
11060606
20.

Slow photoelectron imaging.

Nicole C, Sluimer I, Rosca-Pruna F, Warntjes M, Vrakking M, Bordas C, Texier F, Robicheaux F.

Phys Rev Lett. 2000 Nov 6;85(19):4024-7.

PMID:
11056615

Supplemental Content

Loading ...
Support Center